SCHEMBL3357323

SCHEMBL3357323

[c]1ccccc1SOc1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.33
TSHR P16473 1/20 0.33
CA4 P22748 1/20 0.31
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13518173 0.74
SCHEMBL4921731 0.74
SCHEMBL6485155 0.73
SCHEMBL7504371 0.72 SRC (0.30)
SCHEMBL4915979 0.69
SCHEMBL11703464 0.69
SCHEMBL819437 0.69 MAPT (0.32)
SCHEMBL2423602 0.69
SCHEMBL440187 0.67
SCHEMBL5695838 0.67 LTA4H (0.43) LTA4HTSHRCA4CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7803945-B2 Tetrahydropyridothiophenes 4SC AG (DE) 2010-09-28 US claimed
US-7723523-B2 Tetrahydropyridothiophenes 4SC AG (DE) 2010-05-25 US claimed
US-20090270378-A1 NOVEL TETRAHYDROPYRIDOTHIOPHENES NYCOMED GMBH (DE) 2009-10-29 US claimed
EP-1753512-B1 TETRAHYDROPYRIDOTHIOPHENES NYCOMED GMBH (DE) 2008-07-09 EP claimed
US-20070244112-A1 Novel tetrahydropyridothiophenes ALTANA PHARMA AG (DE) 2007-10-18 US claimed
EP-1753512-A2 TETRAHYDROPYRIDOTHIOPHENES Altana Pharma AG (DE) 2007-02-21 EP claimed
WO-2005118071-A2 TETRAHYDROPYRIDOTHIOPHENES ALTANA PHARMA AG (DE) 2005-12-15 WO claimed
EP-0685474-B1 Oxalylamino-benzofuran- and benzothienyl-derivatives BAYER AG (DE) 1998-09-16 EP claimed
US-5565488-A ANTIINFLAMMATORY AGENTS BAYER AKTIENGESELLSCHAFT (DE) 1996-10-15 US claimed
EP-0685474-A1 Oxalylamino-benzofuran- and benzothienyl-derivatives BAYER AG (DE) 1995-12-06 EP claimed
CN-1055357-A N-alkynes-2-chlorine-acetyl-phenyl derivative and the weedicide that contains this compound CENTRAL GLASS CO LTD (JP) 1991-10-16 CN claimed
CN-116554207-A Organic compound containing imidazo-aza-phenyl group, and preparation method and application thereof 烟台先进材料与绿色制造山东省实验室 2023-08-08 CN disclosed
US-11706981-B2 Organic light emitting device and compounds for use in same IDEMITSU KOSAN CO., LTD. (JP) 2023-07-18 US disclosed
CN-109311904-B Certain substituted benzofuro-and benzothienoquinolines for use in organic light emitting diodes 出光兴产株式会社 2022-03-29 CN disclosed
US-20200227652-A1 ORGANIC LIGHT EMITTING DEVICE AND COMPOUNDS FOR USE IN SAME IDEMITSU KOSAN CO., LTD. (JP) 2020-07-16 US disclosed
US-5565488-A ANTIINFLAMMATORY AGENTS BAYER AKTIENGESELLSCHAFT (DE) 1996-10-15 US disclosed
EP-0685474-A1 Oxalylamino-benzofuran- and benzothienyl-derivatives BAYER AG (DE) 1995-12-06 EP disclosed
CN-1055357-A N-alkynes-2-chlorine-acetyl-phenyl derivative and the weedicide that contains this compound CENTRAL GLASS CO LTD (JP) 1991-10-16 CN disclosed
CN-1055357-A N-alkynes-2-chlorine-acetyl-phenyl derivative and the weedicide that contains this compound CENTRAL GLASS CO LTD (JP) 1991-10-16 CN disclosed
US-4056544-A Anthraquinone compounds BAYER AKTIENGESELLSCHAFT (DT) 1977-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270378-A1 NOVEL TETRAHYDROPYRIDOTHIOPHENES BAX, BCL2, CCAR2 LTA4H 2483/4885TSHR 1110/4885CA4 3763/4885
US-11706981-B2 Organic light emitting device and compounds for use in same SLCO4C1, XPO6, ERCC1 LTA4H 997/4885TSHR 3746/4885CA4 3492/4885
US-20070244112-A1 Novel tetrahydropyridothiophenes BAX, BCL2, BAD LTA4H 2501/4885TSHR 1335/4885CA4 3777/4885
US-20200227652-A1 ORGANIC LIGHT EMITTING DEVICE AND COMPOUNDS FOR USE IN SAME SLCO4C1, XPO6, ERCC1 LTA4H 997/4885TSHR 3746/4885CA4 3492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.